AIM
CBPO

Aigen Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Aigen Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37
Closed -$4K – 1198
2020
Q3 		$4K Sell
37
-4,286
-99% -$460K ﹤0.01% 813
2020
Q2 		$442K Sell
4,323
-7,673
-64% -$821K 0.06% 503
2020
Q1 		$1.29M Buy
11,996
+9,705
+424% +$1.12M 0.17% 158
2019
Q4 		$267K Buy
+2,291
New +$265K 0.04% 471

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Aigen Investment Management's CBPO Position: Q4 2020 in Review

Aigen Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 37 shares — an estimated $4K sold.

Aigen Investment Management first reported a position in CBPO in Q4 2019 and held it in 4 quarters. The position peaked at $1.29M in Q1 2020. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

  • Aigen Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 37 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $4K.
  • Aigen Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's China Biologic Products Holdings, Inc. position peaked at $1.29M in Q1 2020.
  • 89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.